Definition
An allograft is tissue transplanted from one individual to another of the same species — as distinct from an autograft, which comes from the recipient's own body. Connective tissue allografts are donor-derived materials composed of the structural components of connective tissue.
Birth tissue is a common source, including amniotic membrane, umbilical cord tissue and Wharton's jelly. This material is donated following scheduled caesarean delivery, with consent, and is screened and processed under established tissue-banking requirements.
Intended function
These products are intended to provide cushioning and structural support for joints and soft tissue. That phrasing is not marketing softness — it is the specific function permitted under the regulatory category these products occupy, and it defines the limit of what can properly be claimed.
They are not intended or marketed to diagnose, treat, cure or prevent any disease. Any description that goes further has left the regulatory boundary.
The regulatory frame
In the United States, these products are regulated as human cells, tissues, and cellular and tissue-based products — HCT/Ps — under Section 361 of the Public Health Service Act and 21 CFR Part 1271. Products in this category are FDA-registered, not FDA-approved, and are permitted for homologous use only.
Those three terms — Section 361, FDA-registered, homologous use — carry specific meanings that are covered in the articles linked below. Anyone considering these products should understand all three.
This article covers general science and published research. Whether any approach is appropriate for you is a clinical question, answered by a licensed provider through a good-faith exam.
Movera Wellness Institute. Medical services are provided by licensed California practitioners. Supervising physician: Dr. Arnold S. Kremer, DO (CA license #20A4242).